Stockscreener 앱 받기
5.86
3.14%
-0.19
시간 외 거래:
5.80
-0.06
-1.02%
전일 마감가:
$6.05
열려 있는:
$5.9
하루 거래량:
4.02M
Relative Volume:
2.64
시가총액:
$497.74M
수익:
-
순이익/손실:
$-95.90M
주가수익비율:
-4.5426
EPS:
-1.29
순현금흐름:
$-79.09M
1주 성능:
-12.93%
1개월 성능:
+4.64%
6개월 성능:
-16.05%
1년 성능:
-6.84%
1일 변동 폭
$5.785
$6.13
1주일 범위
$5.46
$7.14
52주 변동 폭
$4.32
$11.40
턴스 파마슈티컬스 Stock (TERN) Company Profile
명칭
Terns Pharmaceuticals Inc
전화
650-525-5535 EXT.101
주소
1065 EAST HILLSDALE BLVD., SUITE 100, FOSTER CITY
TERN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TERN
Terns Pharmaceuticals Inc
|
5.86 | 497.74M | 0 | -95.90M | -79.09M | -1.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
턴스 파마슈티컬스 Stock (TERN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-10-31 | 개시 | Oppenheimer | Outperform |
| 2023-06-22 | 개시 | Mizuho | Buy |
| 2023-06-07 | 개시 | Jefferies | Buy |
| 2023-05-31 | 개시 | ROTH MKM | Buy |
| 2023-05-08 | 개시 | BMO Capital Markets | Outperform |
| 2023-02-14 | 개시 | JMP Securities | Mkt Outperform |
| 2023-02-07 | 개시 | UBS | Buy |
| 2022-09-12 | 개시 | H.C. Wainwright | Neutral |
| 2021-09-14 | 재개 | Goldman | Buy |
| 2021-03-02 | 개시 | Cowen | Outperform |
| 2021-03-02 | 개시 | Goldman | Buy |
| 2021-03-02 | 개시 | JP Morgan | Overweight |
모두보기
턴스 파마슈티컬스 주식(TERN)의 최신 뉴스
Terns Pharmaceuticals (NASDAQ:TERN) Trading Down 4.7%Should You Sell? - MarketBeat
Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Shares Bought by Charles Schwab Investment Management Inc. - Defense World
Terns Pharmaceuticals' SWOT analysis: promising pipeline drives stock potential - Investing.com
Is Terns Pharmaceuticals, Inc. (TERN) the Best Weight Loss Stock to Buy Now According to Hedge Funds? - Insider Monkey
Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Stake Reduced by Fmr LLC - MarketBeat
Insider Spends US$110k Buying More Shares In Terns Pharmaceuticals - Simply Wall St
Terns Pharmaceuticals CEO & Director Acquires 423% More Stock - Yahoo Finance
Terns Pharmaceuticals (NASDAQ:TERN) Shares Gap Up Following Insider Buying Activity - Defense World
Terns pharmaceuticals CEO Amy Burroughs acquires $110,467 in stock - Investing.com India
Terns pharmaceuticals CEO Amy Burroughs acquires $110,467 in stock By Investing.com - Investing.com Canada
17,369 Shares in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Bought by Intech Investment Management LLC - Defense World
Terns Pharmaceuticals' SWOT analysis: stock poised for growth amid clinical milestones By Investing.com - Investing.com South Africa
Terns Pharmaceuticals' SWOT analysis: stock poised for growth amid clinical milestones - Investing.com
Terns Pharma broadens beyond obesity drugs with upbeat data in leukemia trial - MSN
Walleye Capital LLC Takes $1.55 Million Position in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - MarketBeat
Terns’s stock soars as analysts cheer leukemia data — and predict more gains - MSN
Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Shares Acquired by Parkman Healthcare Partners LLC - MarketBeat
Cinctive Capital Management LP Buys Shares of 168,564 Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - MarketBeat
Terns reports positive early results in CML drug trial By Investing.com - Investing.com Nigeria
U.S. STOCKS BlackRock, Terns Pharma, PSQ Holdings - XM
Terns Pharmaceuticals Reports Inducement Grant to New Employee under Nasdaq Listing Rule 5635(4) - Marketscreener.com
Terns reports positive early results in CML drug trial - Investing.com
Terns Pharmaceuticals Announces Positive Early Data from - GlobeNewswire
Terns Pharma's CML Drug Shows 50% Response Rate in Phase 1 Trial, Strong Safety Profile - StockTitan
Terns Pharmaceuticals Announces Positive Early Data from Phase 1 CARDINAL Trial of TERN-701 for Chronic Myeloid Leukemia - The Manila Times
Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4) - The Manila Times
Quantbot Technologies LP Has $1.01 Million Stock Holdings in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - MarketBeat
Comparing Enliven Therapeutics (NASDAQ:ELVN) & Terns Pharmaceuticals (NASDAQ:TERN) - Defense World
Bellevue Group AG Takes $8.69 Million Position in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - MarketBeat
Acuta Capital Partners LLC Boosts Position in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - MarketBeat
Analysts Set Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Price Target at $27.25 - Defense World
Terns Pharmaceuticals (TERN) Stock Surges Over 5% Amid Biotech S - GuruFocus.com
Companies To Watch: Terns Pharmaceuticals - Life Science Leader Magazine
Terns Pharmaceuticals' SWOT analysis: stock poised for key data readouts By Investing.com - Investing.com Canada
Terns Pharmaceuticals' SWOT analysis: stock poised for key data readouts - Investing.com
Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Telemark Asset Management LLC Acquires Shares of 300,000 Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - MarketBeat
Non-alcoholic Steatohepatitis (NASH) Treatment Market 2032: Clinical Trials, Medication, EMA, PDMA, FDA Approvals, Epidemiology, Therapies, Companies by DelveInsight - The Globe and Mail
104,535 Shares in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Purchased by Quest Partners LLC - MarketBeat
Terns Pharmaceuticals (TERN) Stock Drops Over 5% Amidst Mixed In - GuruFocus.com
Top 3 Health Care Stocks You'll Regret Missing In Q4Amarin Corp (NASDAQ:AMRN) - Benzinga
Terns Pharmaceuticals appoints new board member - Investing.com
Terns Pharmaceuticals Appoints Heather Turner, J.D., to Board of Directors - GlobeNewswire
Terns Pharmaceuticals, Inc. Announces Board Changes - Marketscreener.com
Terns Pharmaceuticals Inc (TERN) Stock Price & Chart | Trade Now - Capital.com
Terns Pharmaceuticals (NASDAQ:TERN) Stock Price Down 8.7%Should You Sell? - MarketBeat
Steven Cohen's Strategic Acquisition in Terns Pharmaceuticals Inc - GuruFocus.com
턴스 파마슈티컬스 (TERN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.88%
2.65%
자본화:
|
볼륨(24시간):